Global Zika Virus Testing Market 2020 Top Countries Data Research Reports, Industry Size, In-Depth Qualitative Insights, Explosive Growth Opportunity, Regional Analysis by By 360 Market Updates

Global “Zika Virus Testing Market” Report 2020 offers Complete analysis of industry status and outlook of major regions based on of key players, countries, product types, and end industries. This report focuses on the Zika Virus Testing in Global market, especially in United States, Europe, China, Japan, South Korea, North America, India. Zika Virus Testing Market report categorizes the market based on manufacturers, regions, type and application. Zika Virus Testing Report 2020 (value and volume) by company, regions, product types, end industries, history data and estimate data.

Also, Report contains a comprehensive analysis of the important segments like market opportunities, import/export details, market dynamics, key manufacturers, growth rate, and key regions. Zika Virus Testing Market report categorizes the market based on manufacturers, regions, type, and application. Zika Virus Testing Market reports offer a detailed assessment of the Zika Virus Testing including enabling technologies, current market situation, market assumptions, restraining factors.

Get a Sample PDF of Zika Virus Testing Market 2020

List of Top Key-players in 2020 of Zika Virus Testing Market:-

• Abbott
• Altona Diagnostics GmbH
• Chembio Diagnostic Systems Inc.
• ELITechGroup
• F. Hoffmann-La Roche Ltd
• Fast Track Diagnostics Ltd
• Genekam
• Luminex Corporation
• Primerdesign Ltd
• and Quest Diagnostics

The Global Zika Virus Testing market swot is provided for the international markets including progress trends, competitive landscape breakdown, and key in regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed.

TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT - REQUEST SAMPLE

The global Zika virus testing market is expected to register a CAGR of about 5.5%, during the forecast period of 2018-2023. Zika virus belongs to falvivirus genus transmitted by Ades mosquitoes. The market studied is primarily driven by the increasing R&D activities and rising prevalence of Zika virus infection. By region, due to well-developed healthcare infrastructure and rapid technological advancements by several biopharmaceutical companies in the testing of Zika virus, North America is expected to dominate the market studied.

Increasing Prevalence of Zika Virus Infection
Zika virus (ZIKV) infection has been known to be endemic in Africa and Southeast Asia. The consequent viral spread over the Pacific region led to an outbreak in the developed and emerging countries, worldwide. According to the World health Organization (WHO), about 84 countries/territories are or have been previously infected by ZIKV transmission. There have been major outbreaks of Zika virus infection during 2016-2017, in Asia-Pacific (particularly India) and South American countries. As per the Centers for Disease Control and Prevention, Mexico, South America, Central and Sub-Saharan African countries, and several countries in Southeast Asia are the major countries at risk for the growth of Zika virus infection. Thus, the rising prevalence of Zika virus infection in the emerging countries is one of the primary factors driving the growth of the market studied, over the forecast period.
The other prominent drivers of the market studied are - government initiatives to develop innovative tests, rising R&D efforts by biopharmaceutical companies, and technological advancements in medical diagnostic tests.

High Costs of Testing Kits
The high cost associated with the testing kits is one of the primary factors restricting the growth of the market studied. As per a recent article published in Becker’s Healthcare, the cost of screening is high and positive detections of Zika virus are low. As per the current US Food and Drug Administration (FDA) policy, blood sample from each donation is received individually, which leads to high costs. In the emerging markets like India, the cost is high, and in the range of about INR 4,500–INR 6,000 per test, in leading diagnostic centers, such as Dr. Lal PathLabs, SRL Diagnostics, Quest Diagnostics, and Star Imaging. Further, the laboratory diagnosis infection relies upon RNA in patient specimen and have lower limits of detection.
The other factor restricting the growth of the market studied is the sluggish adoption of new technologies in the emerging economies.

North America is Poised to Dominate
Due to the rising adoption of new technologies in the medical device sector, North America is expected to dominate the market studied. The growth can also be attributed to the rising awareness of the advantages of testing kits. The government organizations, such as CDC, Pan American Health Organization (PAHO), etc., have been mainly involved in the prevention of Zika virus infection. The CDC has received several funding over the past two years, to combat Zika outbreak across several territories. Several companies have been introducing their diagnostic tests, across North and South American countries.

Get a Sample PDF of Report @ https://www.360marketupdates.com/enquiry/request-sample/12886921

The global Zika Virus Testing market covers the vision of participant analysis by product types, market share, applications, sales, and revenue.

Highlighted points of Zika Virus Testing Market Size:

• Covers the varying market dynamics of the industry.
• In-depth analysis of market risks, opportunities, limitations, and growth of the market.
• Includes market driving and restraining factors.
• Participants profiles along with product description, overview, and business data.
• Include details of five years of forecast analysis by types, regions, and applications.

Key Developments in the Zika Virus Testing Market: